
Omnia Bio is a technology-focused, global cell and gene therapy CDMO that specializes in manufacturing gene-modified cell therapies and viral vectors. With a strong emphasis on automation and artificial intelligence within a Good Manufacturing Practices (GMP) environment, Omnia Bio offers comprehensive services from preclinical to commercial manufacturing. Strategically located in Hamilton, Ontario, and backed by over a decade of expertise from CCRM, the company is positioned to meet the surging global demand for cell and gene therapy manufacturing. Omnia Bio's focus on immune cell-based therapies, induced pluripotent stem cell therapies, and lentiviral vectors allows it to drive advancements in the field, ensuring that transformative treatments reach patients effectively.

Omnia Bio is a technology-focused, global cell and gene therapy CDMO that specializes in manufacturing gene-modified cell therapies and viral vectors. With a strong emphasis on automation and artificial intelligence within a Good Manufacturing Practices (GMP) environment, Omnia Bio offers comprehensive services from preclinical to commercial manufacturing. Strategically located in Hamilton, Ontario, and backed by over a decade of expertise from CCRM, the company is positioned to meet the surging global demand for cell and gene therapy manufacturing. Omnia Bio's focus on immune cell-based therapies, induced pluripotent stem cell therapies, and lentiviral vectors allows it to drive advancements in the field, ensuring that transformative treatments reach patients effectively.
Active Vacancy
About OmniaBio:
OmniaBio Inc. is a technology-driven, global CDMO specializing in cell and gene therapies, with a mission to transform biomanufacturing with AI and automation. Located at McMaster Innovation Park in Hamilton, Ontario, OmniaBio leverages over a decade of expertise in regenerative medicine and advanced therapies developed in partnership with CCRM. Committed to digital transformation, OmniaBio integrates automation, robotics, and artificial intelligence into its operations to drive efficiency, enhance quality, and increase throughput. This innovative approach supports end-to-end CDMO services—from development through GMP manufacturing and scale-up—helping clients accelerate the path to market for transformative treatments. OmniaBio focuses on immune cell-based therapies, induced pluripotent stem cell therapies, and lentiviral vectors, positioning itself as a leader in advancing and maturing cell and gene therapy manufacturing. With a strategic vision to meet the surging global demand, OmniaBio aims to enable broad access to cutting-edge therapies worldwide.
Visit www.omniabio.com to learn more.
Position Summary:
As the Associate I, Quality Control at OmniaBio, you are a motivated individual with a keen interest in the field of quality control (QC) for Good Manufacturing Practices (GMP) manufacturing of cell and gene therapy products, driven by the opportunity to enable clinical translation of cell therapy and regenerative medicine. The Associate I, Quality Control, will be required to work across the entire range of activities, including but not limited to, testing, sample management, equipment qualification, method development and optimization, and data review. You will demonstrate flexibility within the Quality team and larger organization, managing work priorities, as required. You will ensure the high-quality delivery of contract services.
Responsibilities:
Requirements:
Desired Characteristics: